BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35070246)

  • 1. Clinical Potential of miR-451 and miR-506 as a Prognostic Biomarker in Patients with Breast Cancer.
    Du Y; Miao Z; Qiu L; Lv Y; Wang K; Guo L
    J Healthc Eng; 2022; 2022():9578788. PubMed ID: 35070246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical potential of miR-940 as a diagnostic and prognostic biomarker in breast cancer patients.
    Liu W; Xu Y; Guan H; Meng H
    Cancer Biomark; 2018; 22(3):487-493. PubMed ID: 29843213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulation of serum miR-1204 and its potential as a biomarker for the diagnosis and prognosis of breast cancer.
    Han S; Li P; Wang D; Yan H
    Rev Assoc Med Bras (1992); 2020 Jun; 66(6):732-736. PubMed ID: 32696863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased expression of microRNA-124 is an independent unfavorable prognostic factor for patients with breast cancer.
    Dong LL; Chen LM; Wang WM; Zhang LM
    Diagn Pathol; 2015 Apr; 10():45. PubMed ID: 25924779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of miRNA-9 and miRNA-34a as potential biomarkers for diagnosis of breast cancer in Iranian women.
    Orangi E; Motovali-Bashi M
    Gene; 2019 Mar; 687():272-279. PubMed ID: 30468908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-875 Serves as A Candidate Biomarker for Detection and Prognosis and Is Correlated with PHH3 Index Levels in Breast Cancer Patients.
    Liu X; Liu M; Ma H; Wang J; Zheng Y
    Clin Breast Cancer; 2022 Feb; 22(2):e199-e205. PubMed ID: 34281802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance.
    Yang L; Xu Q; Xie H; Gu G; Jiang J
    Clin Transl Oncol; 2016 Aug; 18(8):841-7. PubMed ID: 26586116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of miR-199b-5p is correlated with poor prognosis for breast cancer patients.
    Fang C; Wang FB; Li Y; Zeng XT
    Biomed Pharmacother; 2016 Dec; 84():1189-1193. PubMed ID: 27788476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer.
    Xu S; Yi XM; Zhou WQ; Cheng W; Ge JP; Zhang ZY
    Int J Clin Exp Pathol; 2015; 8(11):14335-44. PubMed ID: 26823749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of serum miR-768-3p in HBV-related hepatocellular carcinoma and its potential mechanism.
    Cao C; Wang C
    Clin Exp Med; 2020 Nov; 20(4):569-576. PubMed ID: 32712720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-424 Functions as Potential Diagnostic and Prognostic Biomarker in Melanoma.
    Xu SJ; Xu WJ; Zeng Z; Zhang M; Zhang DY
    Clin Lab; 2020 Jul; 66(7):. PubMed ID: 32658408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased expression of miR-204 is associated with poor prognosis in patients with breast cancer.
    Li W; Jin X; Zhang Q; Zhang G; Deng X; Ma L
    Int J Clin Exp Pathol; 2014; 7(6):3287-92. PubMed ID: 25031750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma.
    Yang Z; Zhang Y; Zhang X; Zhang M; Liu H; Zhang S; Qi B; Sun X
    Biomed Pharmacother; 2015 Oct; 75():153-8. PubMed ID: 26422796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower expression of miR-218 in human breast cancer is associated with lymph node metastases, higher grades, and poorer prognosis.
    Ahmadinejad F; Mowla SJ; Honardoost MA; Arjenaki MG; Moazeni-Bistgani M; Kheiri S; Teimori H
    Tumour Biol; 2017 Aug; 39(8):1010428317698362. PubMed ID: 28857013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of serum miR-411 as a diagnosis and prognosis biomarker for non-small cell lung cancer.
    Wang SY; Li Y; Jiang YS; Li RZ
    Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4092-4097. PubMed ID: 29028091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low serum miR-373 predicts poor prognosis in patients with pancreatic cancer.
    Hua Y; Chen H; Wang L; Wang F; Wang P; Ning Z; Li Y; Liu L; Chen Z; Meng Z
    Cancer Biomark; 2017 Jul; 20(1):95-100. PubMed ID: 28759959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of expression patterns for nine miRNAs in 204 lymph-node negative breast cancers.
    Jonsdottir K; Janssen SR; Da Rosa FC; Gudlaugsson E; Skaland I; Baak JP; Janssen EA
    PLoS One; 2012; 7(11):e48692. PubMed ID: 23144930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-1236-3p serves as a new diagnostic and prognostic biomarker for gastric cancer.
    An JX; Ma ZS; Ma MH; Shao S; Cao FL; Dai DQ
    Cancer Biomark; 2019; 25(2):127-132. PubMed ID: 31045511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum miR-3142 could be Used as a Potential Biomarker to Screen Cervical Cancer Patients from Healthy Controls.
    Luo Q; Wang H; Li J
    Clin Lab; 2019 Apr; 65(4):. PubMed ID: 30969093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased expression of MicroRNA-200 family in human breast cancer is associated with lymph node metastasis.
    Xu F; He H; Huang W; Lin Y; Luo S; Du Q; Duan R
    Clin Transl Oncol; 2016 Mar; 18(3):283-8. PubMed ID: 26201425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.